Individual freedom versus collective responsibility: too many rights make a wrong? by Looker, Katharine J & Hallett, Timothy B
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Emerging Themes in Epidemiology
Open Access Editorial
Individual freedom versus collective responsibility: too many rights 
make a wrong?
Katharine J Looker* and Timothy B Hallett
Address: Department of Infectious Disease Epidemiology, Imperial College London, UK
Email: Katharine J Looker* - k.looker@imperial.ac.uk; Timothy B Hallett - timothy.hallett@imperial.ac.uk
* Corresponding author    
Individuals might reasonably expect the freedom to make their own decisions regarding their
health. However, what happens when an individual's wishes conflict with what is in that individual's
best interests? How far should an individual's rights be restricted for his or her own benefit?
Similarly, what limitations should be placed on an individual's behaviour when that person's wishes
go against what is good for the population in general? Here we discuss the issues that can arise
when the rights of individuals conflict with individual and population benefits in relation to
infectious diseases.
When it comes to health, one might expect to have the
freedom to behave as one chooses within the necessary
legal constraints. An individual can decide, for instance,
whether or not to seek treatment for a bacterial sexually
transmitted infection (STI). The individual probably
wants to be treated as this will alleviate her symptoms and
minimise the possibility of associated complications such
as infertility. With treatment, all her future sexual partners
(and their partners, and so on) will also benefit since they
will be at less risk of contracting the STI, and the burden
on the healthcare system will consequently be reduced.
This is a 'win-win' scenario; the individual wants treat-
ment and this wish will benefit both that individual and
the rest of the population. But what happens when the
wants of the individual are not in line with what will ben-
efit either the individual concerned or the general popula-
tion? When these interests compete, what should be
done?
We can imagine a range of scenarios where these tensions
(individual-level wants versus individual-level benefits
and individual-level benefits versus population-level ben-
efits) are felt (Table 1). For example, an individual may
want to keep a stockpile of the anti-influenza drug Tami-
flu® for his own personal use in case there is an epidemic,
but this will not benefit the population if it deprives those
most at need [1]. Or a parent, believing (incorrectly) that
the measles-mumps-rubella (MMR) vaccine is linked to
autism, may decline vaccination for her child despite this
putting both the child and other individuals at risk of
infection [2].
On the other side of the coin are conflicts involving
actions which an individual would not chose for himself
but which nevertheless are good for the population. In the
best case these actions benefit the individual too; for
instance, an individual may not want to learn that he is
infected with HIV, but knowing his HIV status will likely
enable him to receive treatment, and might prevent him
from transmitting the infection to others. Similarly,
restricting movement during the Severe Acute Respiratory
Syndrome (SARS) epidemic in 2003 reduced the risk of
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infection for everyone [3], though at the cost of some
inconvenience to each individual. However, in the worst
case a particular action does not only go against an indi-
vidual's wishes but actually causes harm to that individ-
ual. For example, some uninfected individuals with flu-
like symptoms could have been put at increased risk of
infection with SARS if they were forcibly held in quaran-
tine during the outbreak [4]. Of course, these issues will
extend to even larger scales, pitting the benefits of differ-
ent populations, countries or even regions against one
another – for instance, would national stockpiles of Tami-
flu® be shared internationally in the face of a worldwide
epidemic, or should each country seek to protect only its
own people directly?
In which of these instances should collective benefit be
prioritised even where this means curtailing individual
freedom? What consideration should be given to what an
individual 'wants' as opposed to what is good for her or
good for everyone else? Economists, epidemiologists and
policy-makers may find themselves naturally considering
the population and maximising what is best overall, min-
imising loss of life, maximising benefit per cost and so on.
But from an ethical or philosophical standpoint, that
misses the importance of preserving individual freedom.
One approach could be to consider individual-level
wants, benefits and population-level outcomes at once,
assigning a weighting to each. However, it is far from clear
what the weightings would be, who would assign them,
under which value system they would be assigned, and
whether that would be comparing like-with-like. Individ-
ual-level benefits are often tangible, direct and character-
ised by a degree of certainty, whereas population benefits
can be diffuse, come via circuitous unseen pathways and
their eventual value may be less certain. Lastly, it is impor-
tant to bear in mind that for even the most refined proto-
cols, doctors only actually see individuals, and when
listening to their personal concerns and wishes, popula-
tion-level benefits – perhaps unproven, theoretical and
anonymous – can seem rather distant.
These issues are not just abstract and in some cases have
been tested in court. In 1905 the US Supreme Court for
the first time upheld the right of the state to vaccinate eve-
ryone, even against their wishes [5]. A British man was
convicted in 2005 of causing grievous bodily harm to a
woman whom he knowingly placed at risk of contracting
HIV [6]. Perhaps individuals would come to want what
would actually benefit them if they appreciated the sci-
ence behind the medicine, while the population-benefit
could gain currency for the individual (and his or her doc-
tor) through an awareness of the theoretical epidemiolog-
ical arguments. But could individuals consistently want
what is good for the population before themselves? Is this
Table 1: A summary of potential conflicts between individual-level wants, individual-level health benefits and population-level health 
benefits.
Individual wants? Individual benefit exceeds 
individual harm?
Population benefit exceeds 
population harm?
Examples
Seeking treatment for a bacterial STD; staying 
home when ill with a gastro-intestinal infection
Disclosing HIV status to partner; voluntarily 
revealing personal information for the purposes of 
disease surveillance
Acquiring a personal stock-pile of Tamiflu®; being 
prescribed anti-malarials associated with least 
drug resistance
Refusing the MMR vaccine; pressuring physician 
for antibiotics for a non-bacterial infection
Forcing infected individuals to undergo treatment 
for TB; restricting the movement of persons 
during the SARS outbreak
Forcibly quarantining suspected SARS cases; 
potentially rationing Tamiflu® during an outbreak 
due to limited drug availability
Withholding suppressive therapy which could 
otherwise prevent onward transmission of genital 
herpes because of contraindications in patient
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another example of when the 'good-for-the-group'
instinct [7] is overridden by the compulsion for self-pres-
ervation [8]?
To offer their insights into these issues, we have invited
members of inter-related disciplines to write briefly in
reply to the question; "Under what circumstances should
an individual's rights be restricted for the benefit of the
individual or the population?" [9-11].
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